Periodic Reporting for period 1 - RetinArt (Clinical biomarker for arterial hypertension based on micro-vascular retinal imaging)
Reporting period: 2014-10-01 to 2015-03-31
Pilot clinical studies have delivered substantial findings: the new assessment technique appeared reproducible, highly sensitive for tracking short-term therapeutic effects, and strongly predictive for CVDs. Moreover multiple interviews of medical experts have indicated strong interest in the cardiology and neurology areas, in addition to ophthalmology. These discussions have also led to define the investigations needed for full clinical validation.
The project results have confirmed that Imagine Eyes’ micro-vascular biomarker assessment technology has a huge potential for lifesaving applications in cardiology and neurology. The clinical validation defined in RetinArt will be a key step for establishing a new standard of care that may benefit millions of patients.